Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL LASER ENDOMICROSCOPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL LASER ENDOMICROSCOPY MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 SALES DATA VOLUME
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL LASER ENDOMICROSCOPY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 VALUE CHAIN ANALYSIS
15 HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.1 ECONOMIC DEVELOPMENT
16 GLOBAL LASER ENDOMICROSCOPY MARKET, BY TYPE
16.1 OVERVIEW
16.2 CONFOCAL LASER ENDOMICROSCOPY (CLE)
16.2.1 BY TYPE
16.2.1.1. POINT SCANNING ENDOMICROSCOPES
16.2.1.2. FIBRE BUNDLE ENDOMICROSCOPES
16.2.2 BY PRODUCT
16.2.2.1. PROBE-BASED
16.2.2.2. ENDOSCOPY-BASED
16.2.3 BY EMISSION FILTER
16.2.3.1. GREEN FILTER
16.2.3.2. RED FILTER
16.2.3.3. NEUTRAL FILTERS
16.2.4 OTHERS
16.3 VOLUMETRIC LASER ENDOMICROSCOPY (VLE)
17 GLOBAL LASER ENDOMICROSCOPY MARKET, BY PRODUCT TYPE
17.1 OVERVIEW
17.2 SYSTEMS
17.2.1 BY TYPE
17.2.1.1. SYSTEMS WITH OPTICAL FIBRES
17.2.1.2. SYSTEMS WITH VIDEO PROCESSOR
17.2.2 BY MODALITY
17.2.2.1. HANDHELD
17.2.2.2. WORKBENCH
17.2.3 OTHERS
17.3 DYES
17.3.1 FLOURESCEIN
17.3.2 ACRIFLAVINE HYDROCHLORIDE
17.3.3 CRESYL VIOLET
17.3.4 OTHERS
17.4 SOFTWARE
18 GLOBAL LASER ENDOMICROSCOPY MARKET, BY LASER TECHNOLOGY
18.1 OVERVIEW
18.2 CONFOCAL LASER
18.3 FLUORESCENCE LASER
19 GLOBAL LASER ENDOMICROSCOPY MARKET, BY APPLICATION
19.1 OVERVIEW
19.2 CLINICAL APPLICATIONS
19.2.1 APPLICATIONS IN GASTROENTEROLOGY
19.2.1.1. COLORECTAL CANCER
19.2.1.1.1. PROBE-BASED
19.2.1.1.2. ENDOSCOPY-BASED
19.2.1.2. INFLAMMATORY BOWEL DISEASES
19.2.1.2.1. PROBE-BASED
19.2.1.2.2. ENDOSCOPY-BASED
19.2.1.3. BARRETT’S ESOPHAGUS
19.2.1.3.1. PROBE-BASED
19.2.1.3.2. ENDOSCOPY-BASED
19.2.1.4. GASTRIC CANCER
19.2.1.4.1. PROBE-BASED
19.2.1.4.2. ENDOSCOPY-BASED
19.2.1.5. COELIAC DISEASE
19.2.1.5.1. PROBE-BASED
19.2.1.5.2. ENDOSCOPY-BASED
19.2.2 APPLICATIONS IN HEPATOLOGY
19.2.2.1. PROBE-BASED
19.2.2.2. ENDOSCOPY-BASED
19.2.3 APPLICATIONS IN OVARIAN CANCER
19.2.3.1. PROBE-BASED
19.2.3.2. ENDOSCOPY-BASED
19.2.4 APPLICATIONS IN PULMONOLOGY
19.2.4.1. PROBE-BASED
19.2.4.2. ENDOSCOPY-BASED
19.2.5 APPLICATIONS IN UROLOGY
19.2.5.1. PROBE-BASED
19.2.5.2. ENDOSCOPY-BASED
19.2.6 OTHERS
19.3 PRECLINICAL APPLICATIONS
20 GLOBAL LASER ENDOMICROSCOPY MARKET, BY END USER
20.1 OVERVIEW
20.2 HOSPITALS
20.2.1 PUBLIC
20.2.2 PRIVATE
20.3 DIAGNOSTIC CLINICS
20.4 AMBULATORY SURGICAL CENTERS
20.5 ACADEMIC AND RESEARCH CENTRE
20.6 OTHERS
21 GLOBAL LASER ENDOMICROSCOPY MARKET, BY DISTRIBUTION CHANNEL
21.1 OVERVIEW
21.2 DIRECT TENDER
21.3 THIRD PARTY DISTRIBUTORS
21.4 OTHERS
22 GLOBAL LASER ENDOMICROSCOPY MARKET, BY GEOGRAPHY
GLOBAL LASER ENDOMICROSCOPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
22.1 NORTH AMERICA
22.1.1 U.S.
22.1.2 CANADA
22.1.3 MEXICO
22.2 EUROPE
22.2.1 GERMANY
22.2.2 U.K.
22.2.3 ITALY
22.2.4 FRANCE
22.2.5 SPAIN
22.2.6 RUSSIA
22.2.7 SWITZERLAND
22.2.8 TURKEY
22.2.9 BELGIUM
22.2.10 NETHERLANDS
22.2.11 LUXEMBURG
22.2.12 REST OF EUROPE
22.3 ASIA-PACIFIC
22.3.1 JAPAN
22.3.2 CHINA
22.3.3 SOUTH KOREA
22.3.4 INDIA
22.3.5 SINGAPORE
22.3.6 THAILAND
22.3.7 INDONESIA
22.3.8 MALAYSIA
22.3.9 PHILIPPINES
22.3.10 AUSTRALIA & NEW ZEALAND
22.3.11 REST OF ASIA-PACIFIC
22.4 SOUTH AMERICA
22.4.1 BRAZIL
22.4.2 ARGENTINA
22.4.3 REST OF SOUTH AMERICA
22.5 MIDDLE EAST AND AFRICA
22.5.1 SOUTH AFRICA
22.5.2 EGYPT
22.5.3 SAUDI ARABIA
22.5.4 UNITED ARAB EMIRATES
22.5.5 ISRAEL
22.5.6 REST OF MIDDLE EAST AND AFRICA
23 GLOBAL LASER ENDOMICROSCOPY MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: GLOBAL
23.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.3 COMPANY SHARE ANALYSIS: EUROPE
23.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
23.5 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
23.6 MERGERS & ACQUISITIONS
23.7 NEW PRODUCT DEVELOPMENT & APPROVALS
23.8 EXPANSIONS
23.9 REGULATORY CHANGES
23.1 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24 GLOBAL LASER ENDOMICROSCOPY MARKET, SWOT AND DBMR ANALYSIS
25 GLOBAL LASER ENDOMICROSCOPY MARKET, COMPANY PROFILE
25.1 SYNECTICS MEDICAL LIMITED
25.1.1 COMPANY OVERVIEW
25.1.2 REVENUE ANALYSIS
25.1.3 GEOGRAPHIC PRESENCE
25.1.4 PRODUCT PORTFOLIO
25.1.5 RECENT DEVELOPMENTS
25.2 IMEDEX S.R.O.
25.2.1 COMPANY OVERVIEW
25.2.2 REVENUE ANALYSIS
25.2.3 GEOGRAPHIC PRESENCE
25.2.4 PRODUCT PORTFOLIO
25.2.5 RECENT DEVELOPMENTS
25.3 COOK
25.3.1 COMPANY OVERVIEW
25.3.2 REVENUE ANALYSIS
25.3.3 GEOGRAPHIC PRESENCE
25.3.4 PRODUCT PORTFOLIO
25.3.5 RECENT DEVELOPMENTS
25.4 ZEISS GROUP
25.4.1 COMPANY OVERVIEW
25.4.2 REVENUE ANALYSIS
25.4.3 GEOGRAPHIC PRESENCE
25.4.4 PRODUCT PORTFOLIO
25.4.5 RECENT DEVELOPMENTS
25.5 MAUNA KEA TECHNOLOGIES
25.5.1 COMPANY OVERVIEW
25.5.2 REVENUE ANALYSIS
25.5.3 GEOGRAPHIC PRESENCE
25.5.4 PRODUCT PORTFOLIO
25.5.5 RECENT DEVELOPMENTS
25.6 BVI
25.6.1 COMPANY OVERVIEW
25.6.2 REVENUE ANALYSIS
25.6.3 GEOGRAPHIC PRESENCE
25.6.4 PRODUCT PORTFOLIO
25.6.5 RECENT DEVELOPMENTS
25.7 PENTAX MEDICAL (A SUBSIDIARY OF HOYA CORPORATION)
25.7.1 COMPANY OVERVIEW
25.7.2 REVENUE ANALYSIS
25.7.3 GEOGRAPHIC PRESENCE
25.7.4 PRODUCT PORTFOLIO
25.7.5 RECENT DEVELOPMENTS
25.8 OPTISCAN IMAGING LTD
25.8.1 COMPANY OVERVIEW
25.8.2 REVENUE ANALYSIS
25.8.3 GEOGRAPHIC PRESENCE
25.8.4 PRODUCT PORTFOLIO
25.8.5 RECENT DEVELOPMENTS
25.9 OLYMPUS CORPORATION
25.9.1 COMPANY OVERVIEW
25.9.2 REVENUE ANALYSIS
25.9.3 GEOGRAPHIC PRESENCE
25.9.4 PRODUCT PORTFOLIO
25.9.5 RECENT DEVELOPMENTS
25.1 MERIT MEDICAL SYSTEMS INC.
25.10.1 COMPANY OVERVIEW
25.10.2 REVENUE ANALYSIS
25.10.3 GEOGRAPHIC PRESENCE
25.10.4 PRODUCT PORTFOLIO
25.10.5 RECENT DEVELOPMENTS
25.11 NINEPOINT MEDICAL, INC.
25.11.1 COMPANY OVERVIEW
25.11.2 REVENUE ANALYSIS
25.11.3 GEOGRAPHIC PRESENCE
25.11.4 PRODUCT PORTFOLIO
25.11.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
26 RELATED REPORTS
27 CONCLUSION
28 QUESTIONNAIRE
29 ABOUT DATA BRIDGE MARKET RESEARCH
